IL154240A0 - 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods - Google Patents
4-pyrimidinamine derivatives, pharmaceutical compositions and related methodsInfo
- Publication number
- IL154240A0 IL154240A0 IL15424001A IL15424001A IL154240A0 IL 154240 A0 IL154240 A0 IL 154240A0 IL 15424001 A IL15424001 A IL 15424001A IL 15424001 A IL15424001 A IL 15424001A IL 154240 A0 IL154240 A0 IL 154240A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- related methods
- pyrimidinamine derivatives
- pyrimidinamine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22379100P | 2000-08-08 | 2000-08-08 | |
PCT/US2001/024659 WO2002012198A2 (fr) | 2000-08-08 | 2001-08-06 | Derives 4-pyrimidinamines, compositions pharmaceutiques et procedes associes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL154240A0 true IL154240A0 (en) | 2003-07-31 |
Family
ID=22837982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15424001A IL154240A0 (en) | 2000-08-08 | 2001-08-06 | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
Country Status (16)
Country | Link |
---|---|
US (3) | US20030008883A1 (fr) |
EP (1) | EP1313713B1 (fr) |
JP (1) | JP2004505952A (fr) |
CN (1) | CN1468225A (fr) |
AR (1) | AR031601A1 (fr) |
AT (1) | ATE398109T1 (fr) |
AU (1) | AU2001281120A1 (fr) |
BR (1) | BR0113165A (fr) |
CA (1) | CA2419030A1 (fr) |
DE (1) | DE60134414D1 (fr) |
HK (1) | HK1054033A1 (fr) |
IL (1) | IL154240A0 (fr) |
MX (1) | MXPA03001226A (fr) |
NZ (1) | NZ524100A (fr) |
WO (1) | WO2002012198A2 (fr) |
ZA (1) | ZA200301868B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2355472T3 (es) | 2002-05-22 | 2011-03-28 | Amgen Inc. | Derivados de aminopirimidina para su uso como ligandos del receptor vaniloide para el tratamiento del dolor. |
US7419984B2 (en) * | 2002-10-17 | 2008-09-02 | Cell Therapeutics, Inc. | Pyrimidines and uses thereof |
JP2007523875A (ja) * | 2003-07-15 | 2007-08-23 | ニューロジェン・コーポレーション | バニロイド受容体リガンドとしての置換ピリミジン−4−イルアミン類縁体 |
CN1826328A (zh) * | 2003-07-22 | 2006-08-30 | 神经能质公司 | 经取代的吡啶-2-基胺类似物 |
RU2377241C2 (ru) * | 2003-11-24 | 2009-12-27 | Ф.Хоффманн-Ля Рош Аг | Производные пиразоло-имидазопиримидина, обладающие антагонистической активностью в отношении кортикотропин-рилизинг фактора (crf) |
CA2556239A1 (fr) * | 2004-02-11 | 2005-08-25 | Amgen Inc. | Ligands du recepteur vanilloide et leurs applications dans des traitements |
MXPA06012613A (es) | 2004-05-07 | 2007-01-31 | Amgen Inc | Derivados heterociclicos nitrogenados como moduladores de proteina cinasa y uso para el tratamiento de angiogenesis y cancer. |
CN1972934A (zh) | 2004-06-28 | 2007-05-30 | 奥坦纳医药公司 | 4,6-二取代嘧啶及其作为蛋白激酶抑制剂的用途 |
US7314933B2 (en) | 2004-10-22 | 2008-01-01 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
HU0900798D0 (en) | 2009-12-21 | 2010-03-01 | Vichem Chemie Kutato Kft | 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
US20130109714A1 (en) * | 2010-03-26 | 2013-05-02 | National University Corporation Hokkaido University | Neurodegenerative disease therapeutic agent |
CA2882733C (fr) * | 2012-08-23 | 2021-07-27 | Virostatics Srl | Nouveaux derives d'aminopyrimidine a disubstitution 4,6 possedant a la fois des substituants aromatiques et halogenes |
CA2932608C (fr) * | 2013-12-11 | 2023-02-14 | Biogen Ma Inc. | Composes biaryliques utiles pour le traitement de maladies humaines en oncologie, en neurologie et en immunologie |
SG11202003441VA (en) * | 2017-10-17 | 2020-05-28 | Merck Patent Gmbh | PYRIMIDINE ΤΒΚ/ΙΚΚε INHIBITOR COMPOUNDS AND USES THEREOF |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5068271A (en) * | 1988-09-21 | 1991-11-26 | Uniroyal Chemical Company, Inc. | Arylenediamine substituted pyrimidines compositions |
DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
US5506231A (en) * | 1989-03-31 | 1996-04-09 | The Children's Medical Center Corporation | Treatment of aids dementia, myelopathy and blindness |
US5519035A (en) * | 1993-07-02 | 1996-05-21 | Cornell Research Foundation, Inc. | Treatment of stroke or in anticipation of the occurrence of brain ischemia |
AU692484B2 (en) * | 1993-10-12 | 1998-06-11 | Du Pont Pharmaceuticals Company | 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
ATE232521T1 (de) * | 1998-03-27 | 2003-02-15 | Janssen Pharmaceutica Nv | Hiv hemmende pyrimidin derivate |
ES2221440T3 (es) * | 1998-10-16 | 2004-12-16 | Daiichi Suntory Pharma Co Ltd | Derivados de acido aminofenoxiacetico como neuroprotectores. |
JP2003146987A (ja) * | 1999-05-31 | 2003-05-21 | Dainippon Pharmaceut Co Ltd | 2−アリールプリン−9−アセトアミド誘導体 |
-
2001
- 2001-08-06 DE DE60134414T patent/DE60134414D1/de not_active Expired - Lifetime
- 2001-08-06 IL IL15424001A patent/IL154240A0/xx unknown
- 2001-08-06 WO PCT/US2001/024659 patent/WO2002012198A2/fr active Application Filing
- 2001-08-06 US US09/922,874 patent/US20030008883A1/en not_active Abandoned
- 2001-08-06 EP EP01959581A patent/EP1313713B1/fr not_active Expired - Lifetime
- 2001-08-06 JP JP2002518176A patent/JP2004505952A/ja active Pending
- 2001-08-06 NZ NZ524100A patent/NZ524100A/en not_active Application Discontinuation
- 2001-08-06 AU AU2001281120A patent/AU2001281120A1/en not_active Abandoned
- 2001-08-06 CN CNA018166938A patent/CN1468225A/zh active Pending
- 2001-08-06 BR BR0113165-6A patent/BR0113165A/pt not_active IP Right Cessation
- 2001-08-06 CA CA002419030A patent/CA2419030A1/fr not_active Abandoned
- 2001-08-06 AT AT01959581T patent/ATE398109T1/de not_active IP Right Cessation
- 2001-08-06 MX MXPA03001226A patent/MXPA03001226A/es active IP Right Grant
- 2001-08-08 AR ARP010103803A patent/AR031601A1/es unknown
-
2003
- 2003-03-06 ZA ZA200301868A patent/ZA200301868B/en unknown
- 2003-03-25 US US10/396,158 patent/US20030212079A1/en not_active Abandoned
- 2003-03-25 US US10/395,971 patent/US20040006094A1/en not_active Abandoned
- 2003-09-08 HK HK03106375.9A patent/HK1054033A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2001281120A1 (en) | 2002-02-18 |
DE60134414D1 (de) | 2008-07-24 |
WO2002012198A3 (fr) | 2002-06-06 |
EP1313713B1 (fr) | 2008-06-11 |
US20040006094A1 (en) | 2004-01-08 |
WO2002012198A2 (fr) | 2002-02-14 |
EP1313713A2 (fr) | 2003-05-28 |
US20030008883A1 (en) | 2003-01-09 |
MXPA03001226A (es) | 2004-09-10 |
US20030212079A1 (en) | 2003-11-13 |
CN1468225A (zh) | 2004-01-14 |
AR031601A1 (es) | 2003-09-24 |
ZA200301868B (en) | 2004-06-25 |
ATE398109T1 (de) | 2008-07-15 |
JP2004505952A (ja) | 2004-02-26 |
BR0113165A (pt) | 2003-07-15 |
NZ524100A (en) | 2005-01-28 |
CA2419030A1 (fr) | 2002-02-14 |
HK1054033A1 (zh) | 2003-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400837A3 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
HUP0301146A3 (en) | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use | |
DZ3313A1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
DZ3311A1 (fr) | Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation | |
HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
IL152448A0 (en) | 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same | |
HUP0302997A3 (en) | Phenylalanine derivatives with alpha4-integrin effect, pharmaceutical compositions containing them and their use | |
IL151952A0 (en) | Aminopyridine derivatives and pharmaceutical compositions containing the same | |
HUP0303069A3 (en) | Imidazole derivatives, pharmaceutical compositions containing them and their use | |
HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
IL154096A0 (en) | Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0303184A3 (en) | Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them | |
IL154240A0 (en) | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods | |
HUP0303204A3 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing them | |
IL153487A0 (en) | Pharmaceutical compositions and methods for use | |
PL374761A1 (en) | N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them | |
IL153897A0 (en) | Pharmaceutical compositions and methods for use | |
IL154986A0 (en) | Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
HK1052168A1 (en) | N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them. |